APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Veterinary Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pet Veterinary Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchPet Veterinary Drug Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Veterinary Drug Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pet Veterinary Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Veterinary Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Veterinary Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pet Veterinary Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pet Veterinary Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Veterinary Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Veterinary Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pet Veterinary Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pet Veterinary Drug include Bayer AG, Zoetis Animal Healthcare, Virbac Group, Vetoquinol, Orion Corporation, Merck Animal Health, Elanco Animal Health Inc., Dechra Pharmaceuticals Plc and Ceva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Veterinary Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Veterinary Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Veterinary Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Veterinary Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Veterinary Drug Segment by Company

Bayer AG

Zoetis Animal Healthcare

Virbac Group

Vetoquinol

Orion Corporation

Merck Animal Health

Elanco Animal Health Inc.

Dechra Pharmaceuticals Plc

Ceva

Boehringer Ingelheim International GmbH

Pet Veterinary Drug Segment by Type

Analgesics

Sedatives

Parasiticides

Anti-Inflammatory

Anti-Infectives

Others

Pet Veterinary Drug Segment by Application

Veterinary Hospitals

Veterinary Clinics

Drug Stores

Pet Veterinary Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Veterinary Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Veterinary Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Veterinary Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Veterinary Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pet Veterinary Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pet Veterinary Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pet Veterinary Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pet Veterinary Drug Industry Trends Table 2. Pet Veterinary Drug Industry Drivers Table 3. Pet Veterinary Drug Industry Opportunities and Challenges Table 4. Pet Veterinary Drug Industry Restraints Table 5. Global Pet Veterinary Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pet Veterinary Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pet Veterinary Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Pet Veterinary Drug Sales Market Share by Manufacturers Table 9. Global Pet Veterinary Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Pet Veterinary Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pet Veterinary Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pet Veterinary Drug Manufacturers, Product Type & Application Table 13. Global Pet Veterinary Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Veterinary Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Analgesics Table 17. Major Manufacturers of Sedatives Table 18. Major Manufacturers of Parasiticides Table 19. Major Manufacturers of Anti-Inflammatory Table 20. Major Manufacturers of Anti-Infectives Table 21. Major Manufacturers of Others Table 22. Global Pet Veterinary Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Pet Veterinary Drug Sales by Type (2021-2026) & (k units) Table 24. Global Pet Veterinary Drug Sales by Type (2027-2032) & (k units) Table 25. Global Pet Veterinary Drug Sales Market Share by Type (2021-2026) Table 26. Global Pet Veterinary Drug Sales Market Share by Type (2027-2032) Table 27. Global Pet Veterinary Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global Pet Veterinary Drug Revenue by Type (2021-2026) & (k units) Table 29. Global Pet Veterinary Drug Revenue by Type (2027-2032) & (k units) Table 30. Global Pet Veterinary Drug Revenue Market Share by Type (2021-2026) Table 31. Global Pet Veterinary Drug Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Veterinary Hospitals Table 33. Major Manufacturers of Veterinary Clinics Table 34. Major Manufacturers of Drug Stores Table 35. Global Pet Veterinary Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Pet Veterinary Drug Sales by Application (2021-2026) & (k units) Table 37. Global Pet Veterinary Drug Sales by Application (2027-2032) & (k units) Table 38. Global Pet Veterinary Drug Sales Market Share by Application (2021-2026) Table 39. Global Pet Veterinary Drug Sales Market Share by Application (2027-2032) Table 40. Global Pet Veterinary Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Pet Veterinary Drug Revenue by Application (2021-2026) & (k units) Table 42. Global Pet Veterinary Drug Revenue by Application (2027-2032) & (k units) Table 43. Global Pet Veterinary Drug Revenue Market Share by Application (2021-2026) Table 44. Global Pet Veterinary Drug Revenue Market Share by Application (2027-2032) Table 45. Global Pet Veterinary Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Pet Veterinary Drug Sales by Region (2021-2026) & (k units) Table 47. Global Pet Veterinary Drug Sales Market Share by Region (2021-2026) Table 48. Global Pet Veterinary Drug Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Pet Veterinary Drug Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Pet Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Pet Veterinary Drug Sales by Country (2021-2026) & (k units) Table 52. North America Pet Veterinary Drug Sales by Country (2027-2032) & (k units) Table 53. Europe Pet Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Pet Veterinary Drug Sales by Country (2021-2026) & (k units) Table 55. Europe Pet Veterinary Drug Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Pet Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Pet Veterinary Drug Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Pet Veterinary Drug Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Pet Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Pet Veterinary Drug Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Pet Veterinary Drug Sales by Country (2027-2032) & (k units) Table 62. Global Pet Veterinary Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Pet Veterinary Drug Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Pet Veterinary Drug Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Pet Veterinary Drug Revenue Market Share by Region (2021-2026) Table 66. Global Pet Veterinary Drug Revenue Market Share by Region (2027-2032) Table 67. Bayer AG Company Information Table 68. Bayer AG Business Overview Table 69. Bayer AG Pet Veterinary Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Bayer AG Pet Veterinary Drug Product Portfolio Table 71. Bayer AG Recent Development Table 72. Zoetis Animal Healthcare Company Information Table 73. Zoetis Animal Healthcare Business Overview Table 74. Zoetis Animal Healthcare Pet Veterinary Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Zoetis Animal Healthcare Pet Veterinary Drug Product Portfolio Table 76. Zoetis Animal Healthcare Recent Development Table 77. Virbac Group Company Information Table 78. Virbac Group Business Overview Table 79. Virbac Group Pet Veterinary Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Virbac Group Pet Veterinary Drug Product Portfolio Table 81. Virbac Group Recent Development Table 82. Vetoquinol Company Information Table 83. Vetoquinol Business Overview Table 84. Vetoquinol Pet Veterinary Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Vetoquinol Pet Veterinary Drug Product Portfolio Table 86. Vetoquinol Recent Development Table 87. Orion Corporation Company Information Table 88. Orion Corporation Business Overview Table 89. Orion Corporation Pet Veterinary Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Orion Corporation Pet Veterinary Drug Product Portfolio Table 91. Orion Corporation Recent Development Table 92. Merck Animal Health Company Information Table 93. Merck Animal Health Business Overview Table 94. Merck Animal Health Pet Veterinary Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Merck Animal Health Pet Veterinary Drug Product Portfolio Table 96. Merck Animal Health Recent Development Table 97. Elanco Animal Health Inc. Company Information Table 98. Elanco Animal Health Inc. Business Overview Table 99. Elanco Animal Health Inc. Pet Veterinary Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Elanco Animal Health Inc. Pet Veterinary Drug Product Portfolio Table 101. Elanco Animal Health Inc. Recent Development Table 102. Dechra Pharmaceuticals Plc Company Information Table 103. Dechra Pharmaceuticals Plc Business Overview Table 104. Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Portfolio Table 106. Dechra Pharmaceuticals Plc Recent Development Table 107. Ceva Company Information Table 108. Ceva Business Overview Table 109. Ceva Pet Veterinary Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Ceva Pet Veterinary Drug Product Portfolio Table 111. Ceva Recent Development Table 112. Boehringer Ingelheim International GmbH Company Information Table 113. Boehringer Ingelheim International GmbH Business Overview Table 114. Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Portfolio Table 116. Boehringer Ingelheim International GmbH Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Pet Veterinary Drug Distributors List Table 120. Pet Veterinary Drug Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Pet Veterinary Drug Product Image Figure 2. Global Pet Veterinary Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Veterinary Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Veterinary Drug Sales (2021-2032) & (k units) Figure 5. Global Pet Veterinary Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pet Veterinary Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Analgesics Image Figure 9. Sedatives Image Figure 10. Parasiticides Image Figure 11. Anti-Inflammatory Image Figure 12. Anti-Infectives Image Figure 13. Others Image Figure 14. Global Pet Veterinary Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Pet Veterinary Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Pet Veterinary Drug Sales Market Share by Type (2021-2032) Figure 17. Global Pet Veterinary Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Pet Veterinary Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Pet Veterinary Drug Revenue Market Share by Type (2021-2032) Figure 20. Veterinary Hospitals Image Figure 21. Veterinary Clinics Image Figure 22. Drug Stores Image Figure 23. Global Pet Veterinary Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Pet Veterinary Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pet Veterinary Drug Sales Market Share by Application (2021-2032) Figure 26. Global Pet Veterinary Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Pet Veterinary Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Pet Veterinary Drug Revenue Market Share by Application (2021-2032) Figure 29. North America Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Pet Veterinary Drug Sales Market Share by Country (2021-2032) Figure 31. U.S. Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Pet Veterinary Drug Sales Market Share by Country (2021-2032) Figure 36. Germany Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Pet Veterinary Drug Sales Market Share by Country (2021-2032) Figure 43. China Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Pet Veterinary Drug Sales Market Share by Country (2021-2032) Figure 51. Brazil Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Pet Veterinary Drug Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Pet Veterinary Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Pet Veterinary Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Figure 62. North America Pet Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Figure 64. Europe Pet Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Pet Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Pet Veterinary Drug Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Pet Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Pet Veterinary Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Pet Veterinary Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Analgesics
  • Sedatives
  • Parasiticides
  • Anti-Inflammatory
  • Anti-Infectives
  • Others
Applications
  • Veterinary Hospitals
  • Veterinary Clinics
  • Drug Stores
Companies covered
  • Bayer AG
  • Zoetis Animal Healthcare
  • Virbac Group
  • Vetoquinol
  • Orion Corporation
  • Merck Animal Health
  • Elanco Animal Health Inc.
  • Dechra Pharmaceuticals Plc
  • Ceva
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pet Veterinary Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pet Veterinary Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pet Veterinary Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pet Veterinary Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pet Veterinary Drug Market Dynamics
  1. 2.1 Pet Veterinary Drug Industry Trends
  2. 2.2 Pet Veterinary Drug Industry Drivers
  3. 2.3 Pet Veterinary Drug Industry Opportunities and Challenges
  4. 2.4 Pet Veterinary Drug Industry Restraints
3 Pet Veterinary Drug Market by Manufacturers
  1. 3.1 Global Pet Veterinary Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pet Veterinary Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pet Veterinary Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pet Veterinary Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pet Veterinary Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pet Veterinary Drug Manufacturers, Product Type & Application
  7. 3.7 Global Pet Veterinary Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pet Veterinary Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pet Veterinary Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pet Veterinary Drug Tier 1, Tier 2, and Tier 3
4 Pet Veterinary Drug Market by Type
  1. 4.1 Pet Veterinary Drug Type Introduction
  2. 4.1.1 Analgesics
  3. 4.1.2 Sedatives
  4. 4.1.3 Parasiticides
  5. 4.1.4 Anti-Inflammatory
  6. 4.1.5 Anti-Infectives
  7. 4.1.6 Others
  8. 4.2 Global Pet Veterinary Drug Sales by Type
  9. 4.2.1 Global Pet Veterinary Drug Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Pet Veterinary Drug Sales by Type (2021-2032)
  11. 4.2.3 Global Pet Veterinary Drug Sales Market Share by Type (2021-2032)
  12. 4.3 Global Pet Veterinary Drug Revenue by Type
  13. 4.3.1 Global Pet Veterinary Drug Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Pet Veterinary Drug Revenue by Type (2021-2032)
  15. 4.3.3 Global Pet Veterinary Drug Revenue Market Share by Type (2021-2032)
5 Pet Veterinary Drug Market by Application
  1. 5.1 Pet Veterinary Drug Application Introduction
  2. 5.1.1 Veterinary Hospitals
  3. 5.1.2 Veterinary Clinics
  4. 5.1.3 Drug Stores
  5. 5.2 Global Pet Veterinary Drug Sales by Application
  6. 5.2.1 Global Pet Veterinary Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Veterinary Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Pet Veterinary Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pet Veterinary Drug Revenue by Application
  10. 5.3.1 Global Pet Veterinary Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pet Veterinary Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Pet Veterinary Drug Revenue Market Share by Application (2021-2032)
6 Global Pet Veterinary Drug Sales by Region
  1. 6.1 Global Pet Veterinary Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Veterinary Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Veterinary Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Pet Veterinary Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pet Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pet Veterinary Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pet Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pet Veterinary Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pet Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pet Veterinary Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pet Veterinary Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pet Veterinary Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pet Veterinary Drug Revenue by Region
  1. 7.1 Global Pet Veterinary Drug Revenue by Region
  2. 7.1.1 Global Pet Veterinary Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pet Veterinary Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Pet Veterinary Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Pet Veterinary Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pet Veterinary Drug Revenue (2021-2032)
  8. 7.2.2 North America Pet Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pet Veterinary Drug Revenue (2021-2032)
  11. 7.3.2 Europe Pet Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pet Veterinary Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pet Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pet Veterinary Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pet Veterinary Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer AG
  2. 8.1.1 Bayer AG Company Information
  3. 8.1.2 Bayer AG Business Overview
  4. 8.1.3 Bayer AG Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bayer AG Pet Veterinary Drug Product Portfolio
  6. 8.1.5 Bayer AG Recent Developments
  7. 8.2 Zoetis Animal Healthcare
  8. 8.2.1 Zoetis Animal Healthcare Company Information
  9. 8.2.2 Zoetis Animal Healthcare Business Overview
  10. 8.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Animal Healthcare Pet Veterinary Drug Product Portfolio
  12. 8.2.5 Zoetis Animal Healthcare Recent Developments
  13. 8.3 Virbac Group
  14. 8.3.1 Virbac Group Company Information
  15. 8.3.2 Virbac Group Business Overview
  16. 8.3.3 Virbac Group Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Virbac Group Pet Veterinary Drug Product Portfolio
  18. 8.3.5 Virbac Group Recent Developments
  19. 8.4 Vetoquinol
  20. 8.4.1 Vetoquinol Company Information
  21. 8.4.2 Vetoquinol Business Overview
  22. 8.4.3 Vetoquinol Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Vetoquinol Pet Veterinary Drug Product Portfolio
  24. 8.4.5 Vetoquinol Recent Developments
  25. 8.5 Orion Corporation
  26. 8.5.1 Orion Corporation Company Information
  27. 8.5.2 Orion Corporation Business Overview
  28. 8.5.3 Orion Corporation Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Orion Corporation Pet Veterinary Drug Product Portfolio
  30. 8.5.5 Orion Corporation Recent Developments
  31. 8.6 Merck Animal Health
  32. 8.6.1 Merck Animal Health Company Information
  33. 8.6.2 Merck Animal Health Business Overview
  34. 8.6.3 Merck Animal Health Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck Animal Health Pet Veterinary Drug Product Portfolio
  36. 8.6.5 Merck Animal Health Recent Developments
  37. 8.7 Elanco Animal Health Inc.
  38. 8.7.1 Elanco Animal Health Inc. Company Information
  39. 8.7.2 Elanco Animal Health Inc. Business Overview
  40. 8.7.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Elanco Animal Health Inc. Pet Veterinary Drug Product Portfolio
  42. 8.7.5 Elanco Animal Health Inc. Recent Developments
  43. 8.8 Dechra Pharmaceuticals Plc
  44. 8.8.1 Dechra Pharmaceuticals Plc Company Information
  45. 8.8.2 Dechra Pharmaceuticals Plc Business Overview
  46. 8.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Portfolio
  48. 8.8.5 Dechra Pharmaceuticals Plc Recent Developments
  49. 8.9 Ceva
  50. 8.9.1 Ceva Company Information
  51. 8.9.2 Ceva Business Overview
  52. 8.9.3 Ceva Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ceva Pet Veterinary Drug Product Portfolio
  54. 8.9.5 Ceva Recent Developments
  55. 8.10 Boehringer Ingelheim International GmbH
  56. 8.10.1 Boehringer Ingelheim International GmbH Company Information
  57. 8.10.2 Boehringer Ingelheim International GmbH Business Overview
  58. 8.10.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Portfolio
  60. 8.10.5 Boehringer Ingelheim International GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Veterinary Drug Value Chain Analysis
  2. 9.1.1 Pet Veterinary Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Veterinary Drug Production Mode & Process
  6. 9.2 Pet Veterinary Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Veterinary Drug Distributors
  9. 9.2.3 Pet Veterinary Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst